|

Prospective Investigation of Multiple Sclerosis in the Three Rivers Region

RECRUITINGSponsored by University of Pittsburgh
Actively Recruiting
SponsorUniversity of Pittsburgh
Started2016-12
Est. completion2047-01
Eligibility
Age7 Years+
Healthy vol.Accepted
Locations1 site

Summary

In this longitudinal prospective natural history study of multiple sclerosis (MS), the overarching goal is to understand the factors that influence individual variation in disease trajectory and treatment response and pave the way for realizing precision medicine in MS. Because MS is a chronic neurological disorder, this observational cohort study will span a 30-year time frame.

Eligibility

Age: 7 Years+Healthy volunteers accepted
Inclusion Criteria:

* Inclusion criteria for MS patients include:

  1. Age 7 years or older
  2. Willing and able to provide consent (for \>=18 years) or assent with permission from at least one of the child's parents (for \<18 years)
  3. Diagnosis of multiple sclerosis or related disorders, including a first central nervous system demyelinating episode with a positive MRI scan or abnormal MRI scans characteristic of MS but no clinical symptoms of the disease
* For healthy controls:

  1. Age 7 years or older
  2. Willing and able to provide consent (for \>=18 years) or assent with permission from at least one of the child's parents (for \<18 years)
  3. No known personal history of multiple sclerosis or related disorders
  4. No other chronic diseases
  5. Family members, unrelated household controls, or controls from the general population could be eligible

There is no exclusion criteria.

Conditions1

Multiple Sclerosis

Locations1 site

University of Pittsburgh
Pittsburgh, Pennsylvania, 15260
Zongqi Xia, MD, PhD412-383-5377

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.